Приклади вживання Enterococcus Англійська мовою та їх переклад на Українською
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
Enterococcus isn't an inherently dangerous bacteria;
Cloning, expression and purification of tRNAPro from bacteria Enterococcus faecalis.
Enterococcus faecalis*(strains sensitive to vancomycin and gentamicin only).
These bacteria include members of Bifidobacterium, Enterococcus, Lactobacillus, and Clostridia.
For example, Enterococcus faecium(DSM 10663/NCIMB 10415) 4b E1707 is registered for use in dogs and cats.
ProBiotic LIVE contains the viable probiotic strain Enterococcus faecium, known for several beneficial health benefits.
The paper, published in the journal Science,has linked autoimmune reactions to a bacteria in the gut called Enterococcus gallinarum.
Gram-positive aerobic Enterococcus spp., Including E. faecalis and E. faecium, Listeria spp.
It occurs when a child enters the body with food from various bacteria(Salmonella,Staphylococcus, Enterococcus, Streptococcus, Proteus, etc.).
Study on the putative active site of Enterococcus faecalis prolyl- tRNA synthetase editing domain by methods of site-directed mutagenesis.
The combination of netilmicin and penicillin G has a synergisticbactericidal effect against most strains of Streptococcus faecalis(enterococcus).
The probiotic microorganism contained in the food, Enterococcus Faecium NCIMB 10415 is approved within the EU to be used for dogs and cats.
Enterococcus faecium is a type of enterococcus that is part of the normal microflora of the human digestive tract, as well as some mammals.
The antimicrobial activity of new two terpenoids(1)&(2) was studied on Escherichia coli, Staphylococcus aureus, Enterococcus faecalis and Pseudomonas aeruginosa.
But some enterococcus strains have evolved into a virulent form, called vancomycin-resistant enterococcus, or VRE, that affects more than 540,000 Americans every year….
Shortly after the procedure, she was admitted to a local hospital with low blood pressure anda dangerous antibiotic-resistant infection by a bacterium called Enterococcus faecalis.
They found that Enterococcus faecalis, Listeria monocytogenes and lactobacilli involved in the fermentation of yogurt, produce electrons directly as described above.
Soon after the procedure, she came to a local hospital with low blood pressure and what turned out to be adangerous antibiotic-resistant infection from a bacteria called Enterococcus faecalis.
A study published in the Journal of Applied Microbiology in April 2009 showed that the essential oil can fight off the bacteria Enterococcus faecium and Enterococcus faecalis, both of which are resistant to the antibiotic vancomycin.
In addition, there is an"intestifag", intended for the treatment of intestinal infections, it includes salmonella, typhoid, dysentery, proteus,coli and streptococcal(enterococcus) phage.
Enterococcus faecium, like other enterococci, is used in the food industry, which uses the ability of enterococci to hydrolyze lactose, ferment milk, effectively suppress pathogenic bacteria in the food itself, as well as their high resistance to acids, salts and high temperature.
There is insufficient evidence to be able to draw any conclusions regarding the possible clinical efficacy of Cubicin against infections due to enterococci, including Enterococcus faecalis and Enterococcus faecium.
A 2012 study in the journal Applied and Environmental Microbiology, which analyzed sand from 53 California beaches,found Escherichia coli and Enterococcus- bacteria typically found in human intestines- as well as Salmonella and Campylobacter, which are sometimes causes of food poisoning.
Synercid is the first antibiotic approved for treatment of patients with serious orlife-threatening infections associated with vancomycin-resistant Enterococcus faecium(VREF) bacteremia.
A 2012 study published in the journal Applied and Environmental Microbiology found that the sand from the 53California beaches contained Escherichia coli and Enterococcus(bacteria commonly found in the human intestines), as well as Salmonella and Campylobacter( bacteria that often cause food poisoning).
We are using the differences between human and prokaryotic enzymes for the development of selectiveinhibitors as potential drugs against Mycobacterium tuberculosis, Enterococcus faecalis and Streptococcus pneumonia.
We are using the differences between human and prokaryotic prolyl-, tyrosyl- and leucyl-tRNA synthetases for the development of theinhibitors as potential drugs against Mycobacterium tuberculosis, Enterococcus faecalis and Streptococcus pneumonia.
Community-acquired Staphyloccus aureus or enterococci, in the absence of primary focus, or.
They are effective against enterococci and Escherichia coli.